185 related articles for article (PubMed ID: 36982385)
21. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
22. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
23. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
[TBL] [Abstract][Full Text] [Related]
24. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
25. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.
Huber SA
Med Microbiol Immunol; 2005 May; 194(3):121-7. PubMed ID: 15107990
[TBL] [Abstract][Full Text] [Related]
26. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
27. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
Gou W; Zhang Z; Yang C; Li Y
Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390
[TBL] [Abstract][Full Text] [Related]
28. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
29. Cell type-specific roles of PAR1 in Coxsackievirus B3 infection.
Bode MF; Schmedes CM; Egnatz GJ; Bharathi V; Hisada YM; Martinez D; Kawano T; Weithauser A; Rosenfeldt L; Rauch U; Palumbo JS; Antoniak S; Mackman N
Sci Rep; 2021 Jul; 11(1):14264. PubMed ID: 34253819
[TBL] [Abstract][Full Text] [Related]
30. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P
Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465
[TBL] [Abstract][Full Text] [Related]
32. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
33. Stem cell factor/mast cell/CCL2/monocyte/macrophage axis promotes Coxsackievirus B3 myocarditis and cardiac fibrosis by increasing Ly6C
Luo Y; Zhang H; Yu J; Wei L; Li M; Xu W
Immunology; 2022 Dec; 167(4):590-605. PubMed ID: 36054617
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
35. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
[TBL] [Abstract][Full Text] [Related]
36. IL-33 enhances macrophage M2 polarization and protects mice from CVB3-induced viral myocarditis.
Wang C; Dong C; Xiong S
J Mol Cell Cardiol; 2017 Feb; 103():22-30. PubMed ID: 28041873
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.
Cihakova D; Barin JG; Afanasyeva M; Kimura M; Fairweather D; Berg M; Talor MV; Baldeviano GC; Frisancho S; Gabrielson K; Bedja D; Rose NR
Am J Pathol; 2008 May; 172(5):1195-208. PubMed ID: 18403598
[TBL] [Abstract][Full Text] [Related]
38. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
39. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
40. Dapagliflozin Alleviates Coxsackievirus B3-induced Acute Viral Myocarditis by Regulating the Macrophage Polarization Through Stat3-related Pathways.
Yan P; Song X; Tran J; Zhou R; Cao X; Zhao G; Yuan H
Inflammation; 2022 Oct; 45(5):2078-2090. PubMed ID: 35676606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]